INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Option exercise
M—
5,491 sh
Jun 1, 2026Jun 3, 2026
Page 735 of 1737
← PrevNext →
traded Jun 1, 2026
+2d
SEC Form 4

Evidence

4
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
14 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$821K
9,986 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$335K
4,246 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$157K
1,938 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$450K
5,655 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

3
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
213 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

3
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

2
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Open-market sale · 10b5-1 plan
SELL$8,236
146 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

2
CT
Chuang Patrick T.Senior VP, Memory Design
GSITGSI TECHNOLOGY INC
Option exercise
M—
40.0K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$79K
1,027 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

1
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$145K
2,542 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$132K
1,700 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,833 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

1
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$67K
1,200 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
262 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$69K
831 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
170 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

0
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
14 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
72.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Grant or award · 10b5-1 plan
A—
60.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$155K
14.9K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
407 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$150
15.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Tax withholding · 10b5-1 plan
F$39K
1,539 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
83.3K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
192 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

0
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
198 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
14.9K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
83.3K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
72.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

0
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Tax withholding · 10b5-1 plan
F$12K
207 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
407 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
198 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

49
DS
Disher StephanieDirector, Chief Executive Officer
ATMUAtmus Filtration Technologies Inc.
Open-market sale
SELL$1.16M
25.7K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

48
CT
Colodney Benjamin TSVP & Chief Accounting Officer
MTDRMatador Resources Co
Open-market purchase
BUY$13K
250 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence